Winpak Operating Income Over Time
| 25W Stock | EUR 30.80 0.20 0.65% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Winpak Performance and Winpak Correlation. Winpak |
Cross Equities Operating Income Analysis
Compare Winpak and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABL | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 1.7 B | 3.6 B | 4.5 B | 5.4 B | 8.4 B | 8.4 B | 6.5 B | 6.8 B | 7.8 B | 5.9 B |
| DAP | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 3 B | 3.4 B | 3.3 B | 4.2 B | 6.4 B | 7.5 B | 5.2 B | 4.9 B | 5.6 B | 5 B |
| 6MK | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 7.3 B | 8.9 B | 12.2 B | 5.5 B | 13.2 B | 18.3 B | 3 B | 20.2 B | 23.3 B | 24.4 B |
| AMD | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | 204 M | 451 M | 631 M | 1.4 B | 3.6 B | 1.3 B | 401 M | 2.1 B | 3.7 B | 3.9 B |
| 4I1 | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 11.5 B | 11.3 B | 10.4 B | 11.6 B | 13 B | 12.2 B | 12.2 B | 13.4 B | 14.9 B | 13.4 B |
| W8V | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 198 B | 176 B |
| TOTB | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 7 B | 15.3 B | 15.4 B | (7.3 B) | 23.9 B | 49.7 B | 30.9 B | 24.1 B | 27.7 B | 20 B |
| AMG | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 10 B | 10.3 B | 9.7 B | 9.1 B | 7.6 B | 9.6 B | 7.9 B | 7.3 B | 9.1 B | 7.2 B |
| HBC1 | 21.1 B | 21.1 B | 21.1 B | 21.1 B | 17 B | 17.2 B | 8.8 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 13.9 B | 12.7 B |
| HK2C | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 7.2 B | 9.5 B | 8.5 B | 11.2 B | 13.6 B | 10.4 B | 8.5 B | 10 B | 11.6 B | 10.4 B |
Winpak and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Operating Income description
Operating Income is the amount of profit realized from Winpak operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Winpak is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Winpak | 25W |
Specialization | Consumer Cyclical, Packaging & Containers |
| Business Address | 100 Saulteaux Crescent, |
| Exchange | Frankfurt Exchange |
EUR 30.8
Other Information on Investing in Winpak Stock
Winpak financial ratios help investors to determine whether Winpak Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Winpak with respect to the benefits of owning Winpak security.